健世科技-B(09877)自主研发的PFO封堵器系统OmniSeal成功完成首例临床应用植入手术
健世科技-B(09877)公布，近日，该公司的全资子公司宁波迪创医疗科技有限公司自主研发的PFO封堵器系统OmniSeal成功完成首例临床应用植入手术。
OmniSeal拥有多项创新设计优势，其独特的完全可穿刺式设计，可实现左心系统二次介入术。OmniSeal可适应不同卵圆孔未闭解剖学结构和形态，降低术后心律失常、房颤等并发症;在确保有效封堵的同时，减少残余分流，降低血栓形成的风险。
此次成功完成OmniSeal首例临床应用植入，验证了OmniSeal的设计优势，亦标志着该公司针对卵圆孔未闭疾病的产品正式迈入新阶段，这是继迪创医疗左心耳封堵器、房间隔分流器以后，第三个进入临床试验的创新产品。该公司将持续针对结构性心脏病开发创新产品，围绕结构心心脏病进行更加全面的商业化布局，以为广大的结构性心脏病患者提供完整的解决方案。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.